Hypertensive Heart Disease and Obesity: A Complex Interaction Between Hemodynamic and Not Hemodynamic Factors

No abstract is available for this paper.

• Publication year

  2014

• Venue

  High Blood Pressure & Cardiovascular Prevention

• Publication date

  2014-05-13

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s40292-014-0054-3PMID 24821373
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Practice guidelines for themanagement of arterial hypertension of the European Society of Hypertension ( ESH ) and the European Society of Cardiology ( ESC ) ESH / ESCTask Force for theManagement of Arterial Hypertension

  2018cited by this paper
• Excess dietary sodium and inadequate potassium intake in Italy: results of the MINISAL study.

  2013cited by this paper
• Overweight and obesity prevalence and determinants in Italy: an update to 2010

  2013cited by this paper
• Plasma aldosterone is increased in class 2 and 3 obese essential hypertensive patients despite drug treatment.

  2012cited by this paper
• Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes.

  2012cited by this paper
• Childhood adiposity, adult adiposity, and cardiovascular risk factors.

  2011cited by this paper
• Predictive role of the nighttime blood pressure.

  2011cited by this paper
• A Murine Model of Isolated Cardiac Steatosis Leads to Cardiomyopathy

  2011cited by this paper
• Long-term effects of weight-reducing diets in hypertensive patients.

  2011cited by this paper
• The Association of Left Ventricular Hypertrophy with Metabolic Syndrome is Dependent on Body Mass Index in Hypertensive Overweight or Obese Patients

  2011cited by this paper
• Obesity Hypoventilation Syndrome: A State-of-the-Art Review

  2010cited by this paper
• Reciprocal regulation of natriuretic peptide receptors by insulin in adipose cells.

  2010cited by this paper
• A translational approach to hypertensive heart disease.

  2010cited by this paper
• Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications.

  2010cited by this paper
• Clinical diagnosis of metabolic and cardiovascular risks in overweight children: early development of chronic diseases in the obese child

  2010cited by this paper
• NPR-C: a component of the natriuretic peptide family with implications in human diseases

  2010cited by this paper
• Annual medical spending attributable to obesity: payer-and service-specific estimates.

  2009cited by this paper
• Long-Term Weight Loss From Lifestyle Intervention Benefits Blood Pressure?: A Systematic Review

  2009cited by this paper
• Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the Strong Heart Study.

  2009cited by this paper
• Long-term effects of weight-reducing drugs in hypertensive patients.

  2009cited by this paper
• Renin–angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans

  2008cited by this paper
• The Clinical Significance of Metabolic Syndrome in Hypertension: Metabolic Syndrome Increases Cardiovascular Risk

  2008cited by this paper
• Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome.

  2007cited by this paper
• 2013 ESH/ESC Guidelines for the management of arterial hypertension

  2007cited by this paper
• Association of Plasma Natriuretic Peptide Levels With Metabolic Risk Factors in Ambulatory Individuals

  2007cited by this paper
• Central role for ENaC in development of hypertension.

  2005cited by this paper
• Impact of Obesity on 24-Hour Ambulatory Blood Pressure and Hypertension

  2005cited by this paper
• TGF-beta1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activation.

  2005cited by this paper
• Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled.

  2004cited by this paper
• Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease

  2004cited by this paper
• Hypertensive Myocardial Fibrosis and Diastolic Dysfunction: Another Model of Inflammation?

  2004cited by this paper
• Aldosterone--villain or bystander?

  2004cited by this paper
• Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

  2002cited by this paper
• Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

  2002cited by this paper
• Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice.

  2001cited by this paper
• Cardiac fibrosis in mice lacking brain natriuretic peptide.

  2000cited by this paper
• The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system.

  1999cited by this paper
• Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production.

  1999cited by this paper
• Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives.

  1999cited by this paper
• Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes.

  1997cited by this paper
• Tumor Necrosis Factor-α Provokes a Hypertrophic Growth Response in Adult Cardiac Myocytes

  1997cited by this paper
• Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients

  1997cited by this paper
• Commentary: Strength and importance of the relation of dietary salt to blood pressure

  1996cited by this paper
• Expression of natriuretic peptide receptors in human adipose and other tissues

  1996cited by this paper
• Fasting inhibits natriuretic peptides clearance receptor expression in rat adipose tissue

  1995cited by this paper
• The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure.

  1995cited by this paper
• Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension.

  1993cited by this paper
• Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts.

  1993cited by this paper
• Comparative analysis of atrial natriuretic peptide receptor expression in rat tissues

  1993cited by this paper
• Myocardial fibrosis: functional significance and regulatory factors.

  1993cited by this paper
• Hypertension‐Induced Changes of Platelet‐Derived Growth Factor Receptor Expression in Rat Aorta and Heart

  1991cited by this paper
• Effects of Hypertension and Aging on Platelet‐Derived Growth Factor and Platelet‐Derived Growth Factor Receptor Expression in Rat Aorta and Heart

  1991cited by this paper
• Effect of hypertension on fibronectin expression in the rat aorta.

  1990cited by this paper
• The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents.

  1989cited by this paper
• Growth factor expression in aorta of normotensive and hypertensive rats.

  1989cited by this paper
• Physiological role of silent receptors of atrial natriuretic factor.

  1987cited by this paper
• [Internal medicine and geriatrics].

  1980cited by this paper
• Blood Pressure, Sodium Intake, and Sodium Related Hormones in the Yanomamo Indians, a “No‐salt” Culture

  1975cited by this paper
• Blood pressure and dietary salt in human populations.

  1973cited by this paper

• Hypertensive heart disease mortality trends attributable to high body mass index over the period 1990–2021 and projections up to 2040

  2025cites this paper
• Global prevalence and disability-adjusted life years of hypertensive heart disease: A trend analysis from the Global Burden of Disease Study 2019

  2024cites this paper
• Trends in disease burden of type 2 diabetes, stroke, and hypertensive heart disease attributable to high BMI in China: 1990–2019

  2024cites this paper
• Single-pill fixed-dose drug combinations to reduce blood pressure: the right pill for the right patient

  2022cites this paper
• Role of Cardiac Natriuretic Peptides in Heart Structure and Function

  2022cites this paper
• Seasonal variation of ambulatory blood pressure in Chinese hypertensive adolescents

  2022cites this paper
• Associations of time-varying obesity and metabolic syndrome with risk of incident heart failure and its subtypes: Findings from the Multi-Ethnic Study of Atherosclerosis.

  2021cites this paper
• The Identikit of Patient at Risk for Severe COVID-19 and Death: The Dysregulation of Renin-Angiotensin System as the Common Theme

  2021cites this paper
• The Number of Pills, Rather Than the Type of Renin–Angiotensin System Inhibitor, Predicts Ambulatory Blood Pressure Control in Essential Hypertensives on Triple Therapy: A Real-Life Cross-Sectional Study

  2021cites this paper
• Effects of angiotensin receptor neprilysin inhibitor on renal function in patients with heart failure: a systematic review and meta-analysis

  2021cites this paper
• Association of body mass index and waist circumference with high blood pressure in older adults

  2021cites this paper
• Testicles, adipose organ and heart: A new axis in the management of SARS-CoV-2?

  2021cites this paper
• High blood pressure in Chinese youth across categories of BMI and waist circumference.

  2020cites this paper
• Prevalence of Subclinical Carotid Atherosclerosis and Role of Cardiovascular Risk Factors in Older Adults: Atherosclerosis and Aging are Not Synonyms

  2020cites this paper
• Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury

  2020cites this paper
• Use of Renin-Angiotensin System Inhibitors in HypertensivePatients in COVID-19 Era: A Review

  2020cites this paper
• Renal effects of Sacubitril/Valsartan in heart failure with reduced ejection fraction: a real life 1-year follow-up study

  2019cites this paper
• Cardiometabolic risk factors and Framingham Risk Score in severely obese patients: Baseline data from DieTBra trial.

  2019cites this paper
• Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded “Double-Trouble” Lipid Profile in Overweight/Obese

  2019cites this paper
• N-terminal pro B-Type natriuretic peptide is inversely correlated with low density lipoprotein cholesterol in the very elderly.

  2018cites this paper
• Effetti metabolici della chirurgia bariatrica

  2017cites this paper
• Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk

  2017cites this paper
• Plasma renin activity to plasma aldosterone concentration ratio correlates with night-time and pulse pressures in essential hypertensive patients treated with angiotensin-converting enzyme inhibitors/AT1 blockers

  2017cites this paper
• Associations Between Body Mass Index, Ambulatory Blood Pressure Findings, and Changes in Cardiac Structure: Relevance of Pulse and Nighttime Pressures

  2015cites this paper
• Weight loss therapy for clinical management of patients with some atherosclerotic diseases: a randomized clinical trial

  2015cites this paper